RNAZ
NASDAQ
$8.73
TransCode Therapeutics Inc (RNAZ)
TransCode Therapeutics, Inc., a biopharmaceutical company, is dedicated to the development and commercialization of drugs for the treatment of metastatic diseases. The company is headquartered in Boston, Massachusetts.
Sector:
Healthcare
Industry:
Biotechnology
Target: $10 (+14.55%)
Market Cap
$7.97M
Price Chart
Valuation
Market Cap$7.97M
P/B6.52
Profitability
EBITDA-$42M
EPS-$45.01
Growth & Risk
Sharpe Ratio0.29